The Akt pathway is a master regulator of cancer cell metabolism [46], components of PI3K/AKT/mTOR pathway are mutated in nearly 25% of breast tumors and are associated with drug responses in ER (+) and ER (−) tumors [47,48,49]. This evidence concerns the gene ESR1 and breast neoplasm.